Parker Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Sell
1,379
-16
-1% -$16.2K 0.19% 23
2025
Q4
$1.5M Sell
1,395
-178
-11% -$170K 0.21% 22
2025
Q3
$1.2M Sell
1,573
-246
-14% -$183K 0.14% 26
2025
Q2
$1.42M Sell
1,819
-3,205
-64% -$2.49M 0.2% 27
2025
Q1
$4.15M Sell
5,024
-280
-5% -$233K 0.74% 15
2024
Q4
$4.09M Sell
5,304
-61
-1% -$50.5K 0.64% 17
2024
Q3
$4.75M Sell
5,365
-6,777
-56% -$6.09M 0.75% 13
2024
Q2
$11M Sell
12,142
-6,134
-34% -$4.91M 1.68% 11
2024
Q1
$14.2M Buy
18,276
+17,820
+3,908% +$12.7M 2.21% 12
2023
Q4
$281K Hold
456
0.05% 27
2023
Q3
$245K Hold
456
0.05% 25
2023
Q2
$214K Buy
+456
New +$191K 0.03% 28

Other funds holding LLY

Parker Investment Management's LLY Position: Q1 2026 in Review

Parker Investment Management reduced its Eli Lilly (LLY) stake by 1.1% in Q1 2026, selling an estimated $16.2K and leaving 1,379 shares worth $1.27M. The position accounts for 0.19% of the portfolio, ranked #23.

Parker Investment Management first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $14.2M in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Parker Investment Management held 1,379 shares of Eli Lilly worth $1.27M as of Q1 2026.
  • Parker Investment Management sold 16 Eli Lilly shares in Q1 2026, an estimated $16.2K.
  • Eli Lilly made up 0.19% of Parker Investment Management's portfolio in Q1 2026, its #23 holding.
  • Parker Investment Management first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • Parker Investment Management's Eli Lilly position peaked at $14.2M in Q1 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Parker Investment Management's 13F filing for Q1 2026, filed 13 May 2026.